Serp-1 for the Treatment of Acute Coronary Syndrome

Clinical trial NCT00243308 · TERMINATED

Trial details

NCT number: NCT00243308
Sponsor: Viron Therapeutics Inc
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Unstable Angina Coronary Atherosclerosis Coronary Restenosis

Start date: 2005-10-01
Primary completion: 2008-07-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.